4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-016362
Chief Medical Officer sold 1,187 shares at $21.87 ($25,960)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eisner Mark Chief Medical Officer | 2023-03-02 | Sale | −1,187 | $21.87 | $25,960 | 172,496 | D: show line 1 in the form |
| Open-market sales · 1,187 sh · avg $21.87 · $25,960 | |||||||
Loading xslF345X03/doc4.xml…